
Kuwait approves Sotrovimab Covid-19 treatment: State media
The Peninsula
DUBAI: Kuwait has approved GSK and Vir Biotechnology's Sotrovimab as a treatment for coronavirus, state news KUNA reported on Wednesday.
Kuwait is the second country in the Middle East to approve the use of the antibody treatment for mild to moderate Covid-19 cases, after the United Arab Emirates. Kuwait also announced on Wednesday a $40 million donation to COVAX, the international program designed to help supply developing countries with vaccines against the disease, KUNA said.More Related News

Qatar announces gradual return to in-person learning after Eid; full school attendance from March 29
Doha, Qatar: The Ministry of Education and Higher Education has announced the gradual resumption of in person learning across educational institutions...

Qatar announces gradual return to in-person learning after Eid; full school attendance from March 29
Doha, Qatar: The Ministry of Education and Higher Education has announced the gradual resumption of in person learning across educational institutions...











